Reported 2 months ago
Bayer AG reported strong quarterly sales driven by high demand for new cancer and kidney treatments, with revenue reaching €11.1 billion, surpassing analyst forecasts. The company's CEO, Bill Anderson, is focusing on enhancing its three divisions—pharmaceuticals, consumer health, and agriculture—while implementing job cuts and changes to improve competitiveness. Despite challenges, including ongoing litigation regarding past acquisitions, Bayer remains on track for its cost-saving goals.
Source: YAHOO